Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

Key Points

• Evidence remains limited regarding optimal treatment selection between transcatheter aortic-valve implantation and surgical replacement for low-risk patients with severe aortic stenosis.
• Current clinical practice lacks definitive guidance for low-risk individuals who are eligible for both surgical aortic-valve replacement and transcatheter approaches to manage valve disease.
• Further evaluation of TAVI versus SAVR outcomes in routine clinical settings is needed to establish clear management strategies for low-risk symptomatic patients with aortic stenosis.